Dr Pairat Vibulakaopun, MD | |
527 Benham St, Bonne Terre, MO 63628-1205 | |
(573) 358-5577 | |
Not Available |
Full Name | Dr Pairat Vibulakaopun |
---|---|
Gender | Male |
Speciality | Internal Medicine |
Location | 527 Benham St, Bonne Terre, Missouri |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1427045004 | NPI | - | NPPES |
200424208 | Medicaid | MO |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207R00000X | Internal Medicine | 34125 (Missouri) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Pairat Vibulakaopun, MD Po Box 364, Bonne Terre, MO 63628-0364 Ph: (573) 358-5577 | Dr Pairat Vibulakaopun, MD 527 Benham St, Bonne Terre, MO 63628-1205 Ph: (573) 358-5577 |
News Archive
The U.S. Food and Drug Administration is advising consumers to avoid eating oysters harvested from the San Antonio Bay on or after Nov. 16 due to reports of norovirus-associated illnesses in some people who had consumed oysters harvested from this area, which is located on the Gulf of Texas.
Zika virus infection passes efficiently from a pregnant monkey to its fetus, spreading inflammatory damage throughout the tissues that support the fetus and the fetus's developing nervous system, and suggesting a wider threat in human pregnancies than generally appreciated.
CV Therapeutics, Inc. has announced that the U.S. Food and Drug Administration (FDA) has approved a new, first line indication for Ranexa(R) (ranolazine extended-release tablets) for the treatment of chronic angina.
Baxter International Inc. today announced that the company has submitted a biologics license application (BLA) supplement to the U.S. Food and Drug Administration (FDA) for the approval of prophylaxis treatment of FEIBA NF [Anti-Inhibitor Coagulant Complex], Nanofiltered and Vapor Heated, in patients with hemophilia A or B and inhibitors.
› Verified 9 days ago